Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586131 · ClinicalTrials.gov registry record · Phase 4
Arterial pH and Total Body Nitrogen Balances in APD
A Phase 4 study, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT00586131 is a Phase 4 study that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 8 participants.
The verdict
NCT00586131, a Phase 4 study, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study will test the hypothesis that by slightly lowering the acidity of blood (or increasing the pH), dialysis patients utilize protein and amino acids more efficiently.
Interventions
- DRUG ammonium chloride or sodium citrate/citric acid
- DRUG Sodium citrate/citratic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00586131
The ClinicalTrials.gov registry entry for NCT00586131 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ammonium chloride or sodium citrate/citric acid is the first listed.
NCT00586131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00586131 about?
NCT00586131 is a clinical study titled "Arterial pH and Total Body Nitrogen Balances in APD". This study will test the hypothesis that by slightly lowering the acidity of blood (or increasing the pH), dialysis patients utilize protein and amino acids more efficiently.
What is the current status of trial NCT00586131?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2003-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00586131?
The interventions under investigation include: ammonium chloride or sodium citrate/citric acid (DRUG), Sodium citrate/citratic acid (DRUG).
Who is sponsoring clinical trial NCT00586131?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.